21
Oct 2014
October 21, 2014
Date: October 21, 2014
From the October 10, 2014 issue of The MedTech Strategist, “SinuSys Finds Great Promise in Kinder, Gentler Sinusitis.”
Next-generation interventional ENT company SinuSys reported positive data at one year from its clinical trial of Vent-Os, a new device therapy for chronic sinusitis. With a kinder and gentler therapy option, the company believes it fulfills the need for an office-based (and patient-preferred) sinusitis treatment.
